Advisory expert group

As part of the development of LIB-01, Dicot has entered into agreements with key opinion leaders and experts in the research and medical profession. The purpose of the group is to help in profiling Dicot's drug candidate and preparing it for market authorization.

To date, Dicot has entered into agreements with the following experts:

Harin Padma-Nathan – MD and urologist, has held a professorship in clinical urology at the Keck School of Medicine at the University of Southern California and has received an American Urological Association Fellowship. Dr. Padma-Nathan operates in California, USA.

Dr. Padma-Nathan has been Principal Investigator in over 110 clinical trials, including the development programs for Viagra and Cialis. He has been published frequently, for example three highly regarded articles in the New England Journal of Medicine on Viagra, MUSE and Caverject. The 1998 Viagra article remains the most cited in urology.

François Giuliano – Medical Doctor and PhD, Neuro-Urology Andrology, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, Garches, France and Associate Professor of Therapeutics (Paris-Ile de France Ouest Medical University). 

Professor Giuliano is a clinically active urologist and one of the founders of Pelvipharm, a CRO specializing in preclinical models concerning pharmacological treatment of cardiovascular diseases, sexual dysfunction in women and men, and non-malignant diseases in the lower urinary tract.

Elin Gahm - MD and specialist in general medicine with expertise in sexual medicine.

Dr. Gahm teaches medical students, specialists and other healthcare professionals in sexual medicine. She is the editor and co-author of the book Practical Sexual Medicine. Gahm advises Dicot on sexology and clinical application.